The global market for Arthroscopy Procedure and Products is forecasted to attain USD 7,553.0 million by 2025, expanding at 5.4% CAGR to reach USD 12,762.2 million by 2035. In 2024, the revenue of this market was around USD 7,193.9 million.
The arthroscopy procedure and products market is growing as more people want less invasive surgeries. Patients and doctors like these surgeries better than open ones. They cut down healing time, have fewer problems after, and work better overall. Because of this, doctors now use arthroscopic methods as the go-to way to check and fix joint issues in sports medicine and bone doctor work.
More people are getting joint problems like wear-and-tear arthritis and inflammatory arthritis. This drives up the need for arthroscopy procedures. As people live longer and more become overweight joint troubles are more common. Also new arthroscopic tools are making surgeries more exact and helping patients recover better. These include clear cameras, robot helpers, and implants that the body can absorb.
Looking ahead new tech breakthroughs will make arthroscopy procedures more effective and precise. Adding AI and AR to surgical tools will give surgeons real-time guidance boosting their skills. Also, as healthcare systems grow in developing countries more people will have access to arthroscopy driving market expansion. Ongoing research to improve arthroscopic methods and materials means the market will keep growing, thanks to new ideas and more doctors using these procedures.
Significant changes have occurred over the years within the arthroscopy procedure and products market due to deepening technical competence in minimally invasive surgical techniques. Arthroscopy was, in fact, limited to diagnosis initially since the erstwhile instruments lacked precision as well as flexibility for more complex procedures; with time, innovation paved the way for the gradual introduction of more specialized arthroscopic instruments such as high-resolution cameras, motorized shavers, and advanced suturing equipment, thus permitting diagnosis and treatment to occur in the same procedure.
Concomitantly, the ever-rising awareness of minimally invasive surgery facilitated a further extension of arthroscopy into fields other than just sports medicine, such as cartilage repair and ligament reconstruction. With accelerating incidences of joint disorders, due to rising age and increasing sports activities, demand for the market has been further fueled.
The advanced growth of implant materials, including bioabsorbable and 3D-printed implants, positively influenced surgical outcomes. The transition toward outpatient and ambulatory surgical centers gave the additional benefit of further acceptance of arthroscopy procedures throughout the world.
Explore FMI!
Book a free demo
Rising osteoarthritis cases, high presence of top orthopedic device manufacturers and a greater adoption of advanced minimally invasive procedures are the primary growth drivers for the North American arthroscopy procedure and products market. The USA holds the largest piece of the pie in the region, thanks to a developed healthcare ecosystem, growing investments in sports medicine, and increasing demand for outpatient invasive arthroscopic procedures.
But the expensive arthroscopic implants, reimbursement challenges, and post-surgical infection risks are hindering market growth. The growing adoption of AI-integrated arthroscopy systems, expansion of ambulatory surgical centers specializing in orthopedic procedures, and increasing preference for bioabsorbable implants are expected to drive further market growth in North America.
Europe holds a major market for arthroscopy procedures and products, owing to a growing geriatric population and rising preference for minimally invasive surgical options, and advancement in 3D arthroscopic imaging. The PDP market in countries including Germany, France and the UK is majorly driven by strong healthcare policies, growing importance of sports injury rehabilitation and improving adoption of regenerative medicine in orthopedic therapies.
Challenges such as stringent regulatory requirements under the European Medicines Agency (EMA), high costs of arthroscopic equipment, and disparity in healthcare access in different regions might hinder the growth of the market.
The European market is witnessing increasing adoption of robotics in arthroscopic surgeries, growing government-funded research in cartilage regeneration and increasing partnerships between biotech companies and orthopedic centers. Summary: Tomorrow’s healthcare delivery in orthopedics will be facilitated by Operations on Demand, a concept enabled by advanced technologies and deeply embedded patient-centered care.
Asia-Pacific is growing at a swift pace in the arthroscopic procedure and products market thanks to increasing incidences of joint disorders, rising healthcare investments, and growing adoption of minimally invasive orthopedic surgeries. This study has identified key markets in China, Japan, and India, where growth in the orthopedic market has been stimulated by expanding medical device manufacturing capabilities, increased government initiatives to provide orthopedic care, and a knockout rate of injuries resulting from high participation in sports.
But affordability limits and absence of skilled arthroscopic surgeons and lack of proper awareness of new arthroscopy technique may discourage the penetration of the arthroscopy market. Further, forces like the introduction of international orthopedic device manufacturers, increase in medical tourism for low-cost arthroscopic surgeries, and adoption of telemedicine for postoperative rehabilitation are driving market growth.
In addition, innovations in biodegradable implants and enhanced research in the area of stem-cell-based cartilage repair protocol undoubtedly are improved for better treatment outcomes and long-term joint health fastened in the region.
Challenges
High cost of arthroscopic equipment and procedures is a major challenge
Among the key problems challenging the arthroscopy products and procedure market is that arthroscopic equipment and procedures are costly. Extremely high-tech arthroscopic equipment like high-definition scopes, robot assistance systems, and specialized implants is extremely expensive and thus is beyond the reach of small health clinics and patients of low- and middle-income countries. Furthermore, training surgeons for arthroscopic procedures also imposes an additional cost, and hence the total bill increases.
Reimbursement constraints in most countries also hinder market growth since not all insurance providers fully cover arthroscopy operations, and therefore patients pay out-of-pocket for the procedure. This might dissuade individuals from availing themselves of minimally invasive operations despite their benefits.
To counter this difficulty, businesses are focusing on low-cost product innovation, and the government and healthcare facilities are attempting to expand insurance coverage and payment systems. Nevertheless, cost continues to be relevant so that arthroscopy operations can gain increased usage throughout the world.
Opportunities
Robotic-assisted systems present lucrative growth opportunity
The integration of AI and robotic-assisted systems in arthroscopic procedures stands as one of the defining opportunities in this market. The AI-powered imaging and navigation systems facilitate on-the-spot decision-making that enhances surgical accuracy and decreases complications. Robotic-assisted arthroscopy, on the other hand, provides control and precision, thereby improving patient outcomes and minimizing recovery time.
Furthermore, more preoperative and postoperative rehabilitation are automated by AI-assisted analytics to become cost-and-time-efficient means for medical practitioners, which could open new avenues of accessibility and effectiveness for arthroscopy procedures. Therefore, rising investments in digital health technologies and smart surgical instruments present lucrative growth avenues for industry players.
In developed nations, the rise of AI-and-robotics innovation ensures the brighter future of conventional arthroscopy with increased acceptance while the budding economies steadily build their healthcare infrastructures. Hence, the applicability of AI and robotics will expand, in turn boosting high growth potential for this market.
Advancements in Biodegradable and Bioabsorbable Implants
These implants are creating a paradigm shift in arthroscopy. Bioabsorbable materials will solve these issues, thereby reducing costs and discomfort. PLA and PGA bioabsorb gradually in the body to facilitate natural healing with minimum long-term complications. These implants lower infections and reduce recovery time. The continuous research to enhance their strength and biocompatibility will make bioabsorbable implants even more desirable in arthroscopy and eventually lead to technological advancement and growth in this market segment.
Growth of Robotics and AI in Arthroscopy
The utilization of robotic-assisted arthroscopies together with AI-assisted surgical navigation systems is redefining the precision paradigm within minimally invasive surgery. Surgical robots provide unparalleled dexterity and control, allowing algorithms to improve the accuracy and effectiveness of complex procedures.
AI-and image navigation systems aid real-time decision-making while minimizing errors and improving surgical outcomes. Furthermore, AI-assisted rehabilitation pathways augment recovery processes for patients, thereby increasing compliance and sustaining function in the affected joint over the long term.
Accessibility and integration of robotic and AI technologies into orthopedic practice will consequently lead to wider adoption, thereby transforming the arthroscopy environment and creating patient-beneficial surgical interventions.
The market for arthroscopy procedures and products globally blossomed from 2020 through to 2024, mainly due to the growing incidence of joint-related conditions, sports injuries, and these new-age minimally invasive techniques that are majorly being embraced.
Advances in arthroscopic instruments such as high-definition visualization systems, fluid management devices, and specialized suturing techniques led to accuracy and improvement of the patient outcomes. The growth of the outpatient and ambulatory surgical centers lured patients because patient-related costs and efficiencies were highlighted in strategies compared with inpatient surgeries.
Between the years of 2025 and 2035, the most-critical market would include the robotic-assisted therapies for arthroscopy, followed by the AI-driven diagnostic tools, and lastly, the biodegradable implants. Investment of a lot in research and development is likely to encourage the advent of many personalized and regenerative treatment options such as bioengineered cartilage and tissue scaffolds.
Furthermore, the acceleration in the healthcare infrastructure of the emerging economies along with the demand for early intervention of orthopedic conditions to keep the patients from getting worse generally will rally the chances of development in the market.
| Category | 2020 to 2024 Trends |
|---|---|
| Regulatory Landscape | Regulatory approvals focused on safety and efficacy of arthroscopy products. |
| Technological Advancements | Adoption of high-definition visualization systems and fluid management technologies. |
| Consumer Demand | Growing demand for minimally invasive procedures for faster recovery and reduced complications. |
| Market Growth Drivers | Rise in sports-related injuries, osteoarthritis cases, and improved surgical instruments. |
| Sustainability | Initial steps towards eco-friendly manufacturing and single-use instrument reduction. |
| Supply Chain Dynamics | Reliance on hospital-based distribution networks for arthroscopic devices. |
| Category | 2025 to 2035 Projections |
|---|---|
| Regulatory Landscape | Expansion of guidelines for AI-driven and robotic-assisted arthroscopy, ensuring precision. |
| Technological Advancements | Integration of robotic-assisted arthroscopy, AI-powered diagnostics, and biodegradable implants. |
| Consumer Demand | Increased preference for outpatient procedures and AI-assisted post-operative rehabilitation. |
| Market Growth Drivers | Expansion of regenerative medicine applications and personalized orthopedic solutions. |
| Sustainability | Greater adoption of biodegradable materials and energy-efficient surgical technologies. |
| Supply Chain Dynamics | Digital supply chain optimization and direct-to-consumer surgical kit models for ambulatory care. |
Market Overview
Currently undergoing incremental progress is the arthroscopy products and procedures market in the USA, which is gaining momentum due to an increased incidence of disorders affecting the joints and the growing inclination towards minimally invasive surgery. Add to this an elderly geriatric population and quite a number of sports injuries, and, by those, the entire cause for arthroscopic procedures is built. Advances in sutureless high-definition visualization systems with specialized arthroscopic instruments boost efficiency and outcome in procedures.
Market Growth Factors
Market Forecast
| Country | CAGR (2025 to 2035) |
|---|---|
| United States | 3.7% |
Market Outlook
Market Outlook Germany's arthroscopy market is dominated by a strong focus on precision engineering and high-quality medical device production. The advanced healthcare infrastructure of the country and research and development focus enable the implementation of leading-edge medical technologies, including arthroscopic surgery. An aging population and high quality of life contribute to the demand for minimally invasive surgical procedures.
Market Growth Factors
Market Forecast
| Country | CAGR (2025 to 2035) |
|---|---|
| Germany | 4.3% |
Market Outlook
Greatly depending on the huge Chinese populace and healthcare investment, the arthroscopy market in China is on the verge of a great boom. Significant government support for healthcare infrastructure and access has resulted in a rising demand for modern medical procedures, including arthroscopy. This increase is also supported by rising awareness regarding minimally invasive surgeries and a prosperous middle-class population.
Market Growth Factors
Market Forecast
| Country | CAGR (2025 to 2035) |
|---|---|
| China | 6.3% |
Market Outlook
India's sad is an arthroscopy product and procedure market that is flourishing, with an increase in healthcare units and better emphasis on minimally invasive surgical procedures. The affordable availability of medical solutions, with government efforts towards healthcare access, is growing the market. Awareness regarding sports injuries and joint health creates demand for arthroscopic procedures.
Market Growth Factors
Market Forecast
| Country | CAGR (2025 to 2035) |
|---|---|
| India | 7.1% |
Market Overview
A notable growth in Brazil's arthroscopy procedural and product market can be perceived due to advances in healthcare infrastructure and an ever-increasing focus on advanced medical treatment options. The government's efforts to improve healthcare services and rising acceptance among physicians for minimally invasive procedures are also contributing factors in the rise of this particular market. Sports-related injuries due to a young and healthy lifestyle with active participation in sports activities have resulted in a further demand for arthroscopy.
Market Growth Factors
Market Forecast
| Country | CAGR (2025 to 2035) |
|---|---|
| Brazil | 5.3% |
Arthroscopes are expected to dominate as they provide accurate, efficient, and high resolution images.
These devices are in arthroscopy, that is a minor surgery, and it proves a high-resolution field of view concerning structures that are within a joint. Most arthroscopies conducted include the knee, shoulder, hip, and ankle. Joint conditions can be diagnosed and treated using arthroscopy, as little tissue is destroyed in the whole process.
The rising market needs for arthroscopes can be traced to the growing prevalence of sports injuries, growing numbers of minimally invasive procedures, and the emerging technology in 4K and high-definition arthroscopy cameras.
North America and Europe, being the primary markets for arthroscopes, account for the world's uptake, while Asia-Pacific has been increasing fast with growing orthopedic care infrastructure and medical tourism inflows to the region. Future innovations in arthroscopy include AI-assisted arthroscopy for precision navigation, enhanced visualization through three-dimensional arthroscopic imaging, and single-use disposable arthroscopes-to bring down the burden of infection.
Arthroscopic implants segment holds the second largest share due to increasing demand for advanced fixation solutions
Joint stabilization and ligament reconstruction procedures rely heavily on arthroscopic implants. Suture anchors, meniscal repair devices, and bioabsorbable screws find their extensive applications in anterior cruciate ligament (ACL) repair, rotator cuff repair, and meniscus fixation.
The current market expansion is fueled by its increasing demand for bioresorbable and biocompatible implants, an increasing number of orthopedic surgeries tapped by aging populations, and developments in regenerative implants that integrate tissues.
The market is majorly driven by the adoption of implants in North America and Europe, with a second momentum gaining in the Asia-Pacific region through improved healthcare accessibility and increments in sports-related injuries. Future trends will witness the rise of AI ushering in preoperative planning for implant placement; next-generation bioengineered implants for cartilage regeneration; and 3D-printed custom implants for the personalized orthopedic care track.
Knee arthroscopy segment will dominate as it is the most commonly performed orthopedic procedures
Some of the most frequently performed surgical interventions on the knee joint by orthopaedic surgeons include arthroscopic ACL reconstruction, meniscus repair, and arthroscopic debridement of cartilage. It has been a procedure of choice due to its minimally invasive nature, short recovery period, and fewer complications than those involving open techniques.
Current market trends indicate that the increasing incidence of knee injuries due to sports activities, the increasing volume of patients diagnosed with osteoarthritis, and the increasing demand for outpatient arthroscopic procedures are contributing factors.
The most advanced of these are North America and Europe in the adaptation of knee arthroscopy, with Asia now witnessing rapid increase as improvements continue to be rolled out in terms of surgical operating rooms for provision of contemporary orthopedic methods with government-led health programs at their back.
Future innovations include AI-assisted robotic knee arthroscopy, smart implants with real-time tracking for post-surgical monitoring, and biologic-based knee preservation techniques. Shoulder arthroscopy is also an important segment, with an increasing share of income related to shoulder surgery because of a rise in the incidence of rotator cuff injuries and sports related surgeries.
Shoulder arthroscopy is also a key segment due to rising prevalence of rotator cuff injuries and sports-related surgeries
Shoulder arthroscopy has nowadays become the most common procedure for rotator cuff repair and related labral repairs, and for treatment of shoulder impingement syndrome. Arthroscopy allows visualization and treatment of the shoulder joint disorders with minimal surgical insult. Growing incidence of shoulder injury, increased demand for minimally invasive orthopedic procedures, and the latest trend of suture anchor technology that offers utmost fixation are the drivers of market growth.
North America and Europe lead shoulder arthroscopy, while Asia-Pacific witnesses an increase in adoption due to a rise in sports-related injuries and growth in orthopedic surgery centers. Robotic-assisted arthroscopy, next-generation absorbable implants that promise to enhance healing, and AI-assisted rehabilitation in support of post-surgical recovery are some innovations on the way.
This arthroscopy procedure and products market is witnessing stiff competition propelled by the needs of minimally invasive surgical techniques, advancements in arthroscopic devices, and growing incidences of joint-related disorders. The companies are now investing in advanced arthroscopy systems, high-definition imaging technologies, and AI-assisted surgical navigation to give themselves an edge over the competition.
The market is characterized by mature medical device companies, manufacturers of orthopedic equipment, and emerging providers of arthroscopy technology, all of which play a part in the changing nature of arthroscopic surgery.
Market Share Analysis by Company
| Company Name | Estimated Market Share (%) |
|---|---|
| Arthrex, Inc. | 22-26% |
| Stryker Corporation | 18-22% |
| Smith & Nephew plc | 10-14% |
| Johnson & Johnson | 8-12% |
| CONMED Corporation | 5-9% |
| Other Companies (combined) | 25-38% |
| Company Name | Key Offerings/Activities |
|---|---|
| Arthrex, Inc. | Market leader offering advanced arthroscopy devices, including implants, visualization systems, and surgical instruments. |
| Stryker Corporation | Develops innovative arthroscopy solutions such as 4K endoscopic visualization systems and powered resection tools. |
| Smith & Nephew PLC | Specializes in minimally invasive joint repair technologies, including robotic-assisted arthroscopic surgery. |
| Johnson & Johnson | Provides high-performance arthroscopy instruments and suture anchor systems for sports medicine applications. |
Key Company Insights
Arthrex, Inc.
Arthrex, Incorporated, is a very well-known global leader in arthroscopically assisted orthopaedic surgical procedures and products. It offers very advanced implantable solutions towards minimally invasive surgical procedures in orthopaedic applications.
Known for its high-end arthroscopic implants, suture anchors, and state-of-the-art visualization systems, the company pours a large chunk of capital into R&D along with innovation in its work towards surgical instruments like one-time-use device and biodegradable implant-based approaches, which aim to enhance efficiency in procedures and patient results.
Arthrex provides functional solutions on sports medicine with a robust presence in the market to hospitals, ambulatory surgery centers, and orthopedic clinics. The company further widened its product portfolio with digital health solutions integrated with AI-assisted surgical instruments to improve and optimize arthroscopic procedures.
Stryker Corporation
This is a comprehensive company in terms of developing arthroscopy procedures and products. Its entire line includes arthroscopic instruments, visualization systems, and implants. One of its most established products is an advanced 4K- surgical imaging, along with a very efficient motorized shaver system, and precision-engineered arthroscopic implants.
Stryker's primary focus on robotic-assisted surgery and AI-driven navigation application has placed it in a strategic advantage among the companies at the forefront of minimally invasive orthopedic surgeries. Stryker's global distribution network enhances its ability to attend insufficiently serving hospitals, specialty clinics, and outpatient surgical centers. According to its initiatives for continued technology expansion, Stryker will only be extending its skills to surgeons and improving their patients' recovery outcomes in arthroscopic procedures.
Smith & Nephew plc
Smith & Nephew plc's competency is really that of a leading class manufacturer of arthroscopic surgical solutions and basically derives its reputation from highly complex sports medicine implants and instruments. Among the innovations in its product line are surgical systems with bioabsorbable anchors along with knee as well as shoulder repair systems as well as next-gen devices for suture fixation. In fact, Smith & Nephew has developed a robust pioneering strand in advanced arthroscopic surgical techniques that facilitate minimally invasive orthopedic surgery.
Added to these are the beneficial implications of its artificial intelligence based imaging and applications in robotic assistance and regenerative medicine technology on surgery efficiency and patient-related outcomes in the long term. Smith & Nephew continues to establish influence over arthroscopic innovation by the geographical expansion of emerging markets, along with the consolidation of partnerships and aid networks with healthcare providers.
Johnson & Johnson
Essentially, Johnson & Johnson, via its DePuy Synthes division, becomes another major player in the arthroscopy procedures and products segment, offering the most complete solution in arthroscopic joint repair and reconstruction operations. Its list of products includes very high-precision arthroscopic implants and suture anchors, as well as motorized shaver systems made for knee, shoulder, and hip operations. Digital health application of DePuy Synthes is transforming the way surgery accuracy and efficiency are achieved with an emphasis on robotic-assisted procedures combined with AI-powered surgical planning.
CONMED Corporation
CONMED Corporation is a dominant maker of arthroscopic surgical products with specialty in high-performance visualization systems, fluid management systems, and precision-based arthroscopic implants. The organization is well recognized for its advanced electromechanical instruments and suture-based fixation products, which are most suitable for complex surgeries on joints.
Most of the funds used in R&D activities at CONMED are directed toward improvement in ergonomics of surgeons, enhancement of healing of tissues, as well as reduced patient recovery time. The company indeed serves many hospitals and surgical outpatient facilities with most emphasis placed on digital integration and AI-smart imaging for arthroscopy procedures.
This way, CONMED continues to present itself in the dynamic obtaining market of products and services related to arthroscopies by continuously innovating and updating product lines and improving efficiencies in surgery itself.
Beyond the leading companies, several other manufacturers contribute significantly to the market, enhancing product diversity and technological advancements. These include:
The global Arthroscopy Procedure and Products industry is projected to witness CAGR of 5.4% between 2025 and 2035.
The global Arthroscopy Procedure and Products market stood at USD 7,193.9 million in 2024.
The global Arthroscopy Procedure and Products market is anticipated to reach USD 12,762.2 million by 2035 end.
China is expected to show a CAGR of 6.3% in the assessment period.
The key players operating in the global Arthroscopy Procedure and Products industry are Arthrex, Inc., Stryker Corporation, Smith & Nephew plc, Johnson & Johnson, CONMED Corporation, Medtronic plc, Zimmer Biomet Holdings, Inc., KARL STORZ SE & Co. KG, Olympus Corporation, Richard Wolf GmbH and others.
Arthroscopes, arthroscopic resection systems, arthroscopic fluid management systems, arthroscopic implants, and others
Shoulder arthroscopy, hip arthroscopy, knee arthroscopy, elbow arthroscopy, small joints arthroscopy, and others
Hospitals, academic institutions, ASC and others
North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia & Pacific, Middle East & Africa
Europe super generics market is Segmented by Drug Class, Route of Administration, Indication, Distribution Channel, and Region from 2025 to 2035.
Coxsackievirus Infections Treatment Market – Growth & Drug Innovations 2025 to 2035
Cytokine Release Syndrome Management Market - Trends & Future Outlook 2025 to 2035
Cryotherapy Market Growth - Demand, Trends & Emerging Applications 2025 to 2035
Cryopreservation for In-vitro Fertilization (IVF) Market - Trends & Forecast 2025 to 2035
Radiotherapy Device Market is segmented by External Beam Radiation Therapy Device and Internal Beam Radiation Therapy Device from 2025 to 2035
Arthroscopy Procedure and Products Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
